The renowned global medical device company has a market capitalization of $214.01 million. The company projects 18.6% growth over the next five years. Nevro’s earnings surpassed the Zacks Consensus ...
At Regenerative Neuropathy of O’Fallon, Illinois, highly trained doctors are using a cutting-edge treatment and successfully slowing and often reversing the disease without addictive medications. The ...
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary b ...